Yang Sheng leads delegation to attend ICMRA summit in ROK
Yang Sheng, deputy commissioner of China's National Medical Products Administration (NMPA), led a delegation to Seoul, the Republic of Korea (ROK), to attend the summit and plenary meeting of the International Coalition of Medicines Regulatory Authorities (ICMRA) from Nov 2 to 5, 2026.
Participants exchange views on topics including the application of artificial intelligence in drug regulation, new methodologies and the next-generation regulatory framework, and patient-centered drug development and regulation. The Chinese delegation delivered a report to the plenary meeting and made remarks on these topics during the discussion.
On the sidelines of the event, the Chinese delegation held working talks with delegations from the drug regulatory authorities of the European Union, Singapore, Poland, and the ROK, as well as with representatives of the World Health Organization. The delegates exchanged in-depth views on deepening mutual trust and cooperation in drug regulation. Yang also held working discussions with the heads of the drug regulatory authorities of the United Kingdom, Canada, Denmark, Portugal, Brazil, Egypt, and South Africa to further expand and deepen bilateral cooperation.
Officials from the NMPA's Department of Comprehensive Affairs, Planning and Finance Affairs, Department of Drug Registration, Department of Drug Regulation, and Department of Science, Technology and International Cooperation were present at the meeting.
